1. Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10023 (12th March 2016) Authors: Ledermann, Jonathan A; Embleton, Andrew C; Raja, Fharat; Perren, Timothy J; Jayson, Gordon C; Rustin, Gordon J S; Kaye, Stan B; Hirte, Hal; Eisenhauer, Elizabeth; Vaughan, Michelle; Friedlander, Michael; González-Martín, Antonio; Stark, Daniel; Clark, Elizabeth; Farrelly, Laura; Swart, Ann Marie;... Journal: Lancet Issue: Volume 387:Issue 10023(2016) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗